< Back to previous page
Project
Investigation of DFNA5 as potential biomarker and tumour suppressor gene in 4 solid tumour types.
This research project focuses on DFNA5 based upon strong indications for its role as tumour suppressor gene, its function in apoptosis and its potential role as early biomarker in cancer. DFNA5 was identified in 1998 in our lab, as a gene causing autosomal dominant non syndromic hearing loss [3]. Since then, a number of papers on DFNA5 have been published pointing towards a possible involvement in cancer [4-15].
Date:1 Oct 2016 → 30 Sep 2019
Keywords:TUMOR SUPPRESSOR, BIOMARKERS
Disciplines:Diagnostics, Laboratory medicine, Morphological sciences, Oncology, Medicinal products
Project type:Collaboration project